Two pathogenic CIAS1 mutations and plasma cytokine profile in a Finnish patient with familial cold autoinflammatory syndrome responsive to anakinra [1]

Scandinavian Journal of Rheumatology

Volumn 37, Issue 1, 2008, Pages 75-76

  Kaipiainen Seppanen O ^a   Punnonen, K ^a   Van Gijn, M E ^b   Mononen, T ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ADULT; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FAMILIAL COLD AUTOINFLAMMATORY SYNDROME; FAMILY HISTORY; FEMALE; FINLAND; GENE MUTATION; HUMAN; LABORATORY TEST; LETTER; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANTIRHEUMATIC AGENTS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CYTOKINES; EXONS; FINLAND; GENES, DOMINANT; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MUTATION; MUTATION, MISSENSE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 38149140756     PISSN: 03009742     EISSN: 15027732     Source Type: Journal    
DOI: 10.1080/03009740701691491     Document Type: Letter

References (10)

1. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature Genetics 2001;29:301-5.
2. Hoffman HM, Gregory SG, Mueller JL, Tresierras M, Broide DH, Wanderer AA, et al. Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum Genet 2003;112:209-16.
3. Neven B, Callebaut I, Prieur AM, Feldman J, Bodemer C, Lepore L, et al. Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 2004;103:2809-15.
4. Masters SL, Lobito AA, Chae J, Kastner DL. Recent advances in the molecular pathogenesis of hereditary recurrent fevers. Curr Opin Allergy Clin Immunol 2006;6:428-33.
5. Hoffman HM, Rosengren S, Boyle DL, Cho JY, Nayar J, Mueller JL, et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist. Lancet 2004;364:1779-85.
6. Metyas SK, Hoffman HM. Anakinra prevents symptoms of familial autoinflammatory syndrome and Raynaud's disease. J Rheumatol 2006;33:2085-7.
7. Goldbach-Mansky R, Dailey NJ, Canna SW, Gelabert A, Jones J, Rubin BI, et al. Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 2006;355:581-92.
8. Stojanov S, Weiss M, Lohse P, Belohradsky BH. A novel CIAS1 mutation and plasma/cerebrospinal fluid cytokine profile in a German patient with neonatal-onset multisystem inflammatory disease responsive to methotrexate therapy. Pediatrics 2004;114:124-7.
9. Matsubayashi T, Suguira H, Arai T, Oh-ishi T, Inamo Y. Anakinra therapy for CINCA syndrome with novel mutation in exon 4 of the CIAS1 gene. Acta Paediatr 2006;95:246-9.
10. Prieur AM, Griscelli C, Lampert F, Truchenbrodt H, Guggenheim MA, Lovell DJ, et al. A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analysed in 30 patients. Scand J Rheumatology 1987;Suppl 66:57-68.